Curis, Inc.

Aurigene Discovery Technologies Limited

Aurigene Oncology Limited

Raghuveer K Ramachandra

Muralidhara Ramachandra

Pottayil Govindan N Sasikumar

Timothy L Wyant

Adam S Lazorchak

The present disclosure relates to methods comprising administering compounds that inhibit VISTA and PD-1 (e.g., PD-1, PD-L1, or PD-L2) pathways with a compound that inhibits TIM-3 and PD-1 (e.g., PD-1, PD-L1, or PD-L2) pathways. The disclosure also relates to treatment of disorders by inhibiting an immunosuppressive signal induced by VISTA, TIM-3, PD-1, PD-L1, and/or PD-L2.

Growing community of inventors

Bengaluru, India

Raghuveer K Ramachandra